Peptide antiangiogenic drugs
US6716963B1 · kind B1 · utility
3Cited by
18References
42Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 22, 1999 |
| Grant date | Apr 6, 2004 |
| Priority date | — |
| Expiry date | Nov 22, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K7/06
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Peptides having the formula:A0-A1-A2-A3-A4-A5-A6-A7-A8-A9-A10wherein A0 is selected from hydrogen or an acyl group; A10 is a hydroxyl group or an amino acid amide; and A1, A2, A3, A4, A5, A6, A7, A8, and A9 are amino acyl residues as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.